Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Hopf

Showing results (91-100 of 179) with videos related to

Pageof 18
Sort By:
Hepato-Gastroenterology|May 31, 2001
Induction of T helper cell type 1 response and elimination of HBeAg during treatment with IL-12 in a patient with therapy-refractory chronic hepatitis BH Barth, R Klein, P A Berg, et al.
Journal of Hepatology|January 1, 1996
Treatment of chronic hepatitis C with interferon alpha: long-term follow-up and prognostic relevance of HCV genotypesU Hopf, T Berg, V König, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996
Clinical significance of recurrent primary biliary cirrhosis after liver transplantationM Knoop, W O Bechstein, H Schrem, et al.
Deutsche Medizinische Wochenschrift (1946)|July 8, 1994
[Current status of treatment for chronic viral hepatitis using recombinant interferon alpha]U Hopf, S Küther, V König, et al.
Transplantation Proceedings|February 1, 1997
Kinetics of hepatitis C viremia after orthotopic liver transplantationT Fukumoto, T Berg, Y Ku, et al.
Klinische Wochenschrift|June 1, 1974
A case of agammaglobulinemia characterized by a defect of B-lymphocyte-differentiation to plasma cellsU Hopf, J Knolle, M Bauchinger, et al.
Hepatology (Baltimore, Md.)|September 26, 2000
Randomized, double-blind, placebo-controlled trial of interferon alfa2a with and without amantadine as initial treatment for chronic hepatitis CS Zeuzem, G Teuber, U Naumann, et al.
Clinical and Experimental Immunology|October 1, 1975
Studies on the pathogenesis of chronic inflammatory liver diseases. I. Membrane-fixed IgG on isolated hepatocytes from patientsU Hopf, W Arnold, K H Meyer zum Büschenfelde, et al.
Zeitschrift Fur Gastroenterologie|February 1, 1993
[Primary sclerosing cholangitis (PSC)--humoral immune phenomena, pathogenetic aspects and therapeutic possibilities]U Hopf, R Stemerowicz, O Knigge, et al.
Journal of Clinical & Laboratory Immunology|May 1, 1990
Experimental liver membrane antibodies (LMA) and antibodies against "liver specific protein (LSP)"--a comparative in vitro studyR Stemerowicz, B Möller, H U Jahn, et al.
Pageof 18

Showing results (91-100 of 179) with videos related to

Sort By:
Pageof 18
Hepato-Gastroenterology|May 31, 2001
Induction of T helper cell type 1 response and elimination of HBeAg during treatment with IL-12 in a patient with therapy-refractory chronic hepatitis BH Barth, R Klein, P A Berg, et al.
Journal of Hepatology|January 1, 1996
Treatment of chronic hepatitis C with interferon alpha: long-term follow-up and prognostic relevance of HCV genotypesU Hopf, T Berg, V König, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996
Clinical significance of recurrent primary biliary cirrhosis after liver transplantationM Knoop, W O Bechstein, H Schrem, et al.
Deutsche Medizinische Wochenschrift (1946)|July 8, 1994
[Current status of treatment for chronic viral hepatitis using recombinant interferon alpha]U Hopf, S Küther, V König, et al.
Transplantation Proceedings|February 1, 1997
Kinetics of hepatitis C viremia after orthotopic liver transplantationT Fukumoto, T Berg, Y Ku, et al.
Klinische Wochenschrift|June 1, 1974
A case of agammaglobulinemia characterized by a defect of B-lymphocyte-differentiation to plasma cellsU Hopf, J Knolle, M Bauchinger, et al.
Hepatology (Baltimore, Md.)|September 26, 2000
Randomized, double-blind, placebo-controlled trial of interferon alfa2a with and without amantadine as initial treatment for chronic hepatitis CS Zeuzem, G Teuber, U Naumann, et al.
Clinical and Experimental Immunology|October 1, 1975
Studies on the pathogenesis of chronic inflammatory liver diseases. I. Membrane-fixed IgG on isolated hepatocytes from patientsU Hopf, W Arnold, K H Meyer zum Büschenfelde, et al.
Zeitschrift Fur Gastroenterologie|February 1, 1993
[Primary sclerosing cholangitis (PSC)--humoral immune phenomena, pathogenetic aspects and therapeutic possibilities]U Hopf, R Stemerowicz, O Knigge, et al.
Journal of Clinical & Laboratory Immunology|May 1, 1990
Experimental liver membrane antibodies (LMA) and antibodies against "liver specific protein (LSP)"--a comparative in vitro studyR Stemerowicz, B Möller, H U Jahn, et al.
Pageof 18